The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TP53 gain of function mutation as a prognostic factor in high-methylated metastatic colorectal cancer: Translational research of TRICOLORE study.
 
Kota Ouchi
Honoraria - Asahi Kasei; Lilly; Merck; Taiho Pharmaceutical
 
Shonosuke Wakayama
No Relationships to Disclose
 
Shin Takahashi
Honoraria - Asahi Kasei; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Eisai; Merck; Ono Yakuhin; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Merck Serono; Ono Pharmaceutical
 
Yasuhide Yamada
Honoraria - Boehringer Ingelheim; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst)
 
Yoshito Komatsu
Honoraria - Asahi Kasei; Bayer Yakuhin; Bristol-Myers Squibb Co.; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Medical Review Co., Ltd.; Merck; Mitsubishi Tanabe Pharma; Moroo Co.; Nipro Corporation; Ono Pharmaceutical; Otsuka; Sanofi/Aventis; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - A2 Healthcare; Astellas Pharma; Bayer Yakuhin; BeiGene (Inst); DAIICHI SANKYO CO., LTD.; Eisai; Incyte; IQvia; Lilly (Inst); Mediscience Planning; MSD K.K.; NanoCarrier; Nipro Corporation (Inst); Ono Pharmaceutical; Parexel International Corporation.; Sanofi/Aventis; Shionogi; Sumitomo Dainippon Pharma Co., Ltd.; Sysmex; Taiho Pharmaceutical; Yakult Honsha
 
Ken Shimada
Research Funding - Chugai Pharma; Taiho Pharmaceutical
 
Tatsuro Yamaguchi
Honoraria - Chugai Pharma
 
Hidekazu Shirota
No Relationships to Disclose
 
Masanobu Takahashi
Speakers' Bureau - Bristol-Myers Squibb; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Ono Pharmaceutical
 
Chikashi Ishioka
Honoraria - Asahi Kasei; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin International; Lilly Japan; Nihonkayaku; Ono Pharmaceutical; Otsuka; Sanofi; Shionogi; Taiho Pharmaceutical; Takeda; Tsumura & Co.; Yakult Honsha
Research Funding - Asahi Kasei (Inst); Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan; Nihonkayaku (Inst); Ono Pharmaceutical (Inst); Otsuka; Sanofi; Shionogi; Taiho Pharmaceutical (Inst); Takeda (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst)